Renal Cancer - Results from #5860

Germline genetic variations in PDZD2 and ITPR2 genes are associated with clear cell renal cell carcinoma in Chinese population March 4, 2016

A Rare Finding of a BRAF Mutation in Renal Cell Carcinoma with Response to BRAF-Directed Targeted Therapy March 4, 2016

Reexamining the association between positive surgical margins and survival after partial nephrectomy in a large American cohort March 4, 2016

Prognostic role of urinary collecting system invasion in renal cell carcinoma: a systematic review and meta-analysis March 4, 2016

Surgical Management of Local Recurrences of Renal Cell Carcinoma March 4, 2016

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy March 4, 2016

Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy March 4, 2016

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study March 3, 2016

Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations March 3, 2016

Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER) March 2, 2016

Radiation Exposure of Interventional Radiologists During Computed Tomography Fluoroscopy-Guided Renal Cryoablation and Lung Radiofrequency Ablation: Direct Measurement in a Clinical Setting March 2, 2016

Comparative efficacy and safety of first-line treatments in patients with metastatic renal cell cancer: a network meta-analysis based on phase 3 RCTs March 2, 2016

Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction March 2, 2016

Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High-Risk Renal Tumors March 2, 2016

Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database March 2, 2016

PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis March 2, 2016

Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis March 2, 2016

Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy March 1, 2016

A technetium 99m-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo March 1, 2016

Comparison of Postoperative Morphine Requirements in Renal Donors and Patients With Renal Carcinoma Undergoing Laparoscopic Nephrectomy February 29, 2016

Page 294 of 458